- Home
- JANX vs STBA Comparison
JANX vs STBA Comparison
Compare JANX & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | STBA |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JANX | STBA |
|---|---|---|
| Price | $13.61 | $40.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | ★ $59.18 | $41.25 |
| AVG Volume (30 Days) | ★ 2.0M | 159.8K |
| Earning Date | 02-26-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.46 |
| Revenue | $10,000,000.00 | ★ $391,893,000.00 |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | ★ N/A | $11.70 |
| Revenue Growth | N/A | ★ 1.21 |
| 52 Week Low | $13.26 | $30.84 |
| 52 Week High | $47.58 | $42.95 |
Technical Indicators
Market Signals| Indicator | JANX | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 32.69 | 52.75 |
| Support Level | $13.68 | $39.30 |
| Resistance Level | $14.34 | $41.06 |
| Average True Range (ATR) | 0.46 | 0.76 |
| MACD | 0.43 | -0.00 |
| Stochastic Oscillator | 33.33 | 73.06 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.